Ketone monoester intake attenuates exercise performance decline in normobaric hypoxia: A post‐hoc subgroup analysis of 5 young male adults without acute mountain sickness
Physiological Reports · 2026
DOI: 10.14814/phy2.71136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2026. Verfasst von Myrthe Stalmans und 6 weiteren Autor:innen. Beteiligte Einrichtung: Exercise Physiology Research Group, Department of Movement Sciences, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Hypoxia, Ketones, Exercise. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fonds Wetenschappelijk Onderzoek (FWO), Javna Agencija za Raziskovalno Dejavnost RS (ARRS).
Abstract (Originalsprache)
In hypoxia, endurance performance, sleep, and cognitive function are impaired. Ketone ester (KE) intake can elevate blood, brain, and skeletal muscle oxygenation, making it an interesting strategy to attenuate hypoxia‐induced impairments. Given that acute mountain sickness (AMS) influences these parameters, we evaluated the effects of KE intake in non‐AMS developing individuals. In a larger project, 14 young, healthy, male participants performed a 29‐h protocol at a simulated altitude of 4000–4500 m, involving regular KE or placebo intake. Five participants completed both sessions without developing severe AMS. They completed two maximal incremental cycling tests after 1.5 and 25 h (EX MAX1 and EX MAX2 , resp.) and a combined maximal‐submaximal test after 26.5 h (EX COMBO ), while resting blood, brain, and skeletal muscle oxygenation and cognitive function were regularly (5‐6x) evaluated, and sleep was analyzed. KE did not alter peak power output (PPO) during EX MAX1 or EX MAX2 , but increased PPO by 36 W during EX COMBO . KE increased blood oxygenation before EX MAX1 , EX MAX2 , and EX COMBO and increased muscle oxygenation only before EX COMBO . Sleep and cognitive function were not affected by KE intake. In a non‐AMS developing subgroup, KE appears effective to attenuate high‐intensity endurance performance decline during subacute hypoxic exposure accompanied by repeated exercise until exhaustion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Exercise Physiology Research Group, Department of Movement Sciences, KU Leuven, Leuven, Belgium.
- Department of Cellular and Physiological Sciences, Faculty of Medicine, University of British Columbia, Kelowna, British Columbia, Canada.
- Faculty of Sport, University of Ljubljana, Ljubljana, Slovenia.
- REVAL-Rehabilitation Research Center, Faculty of Rehabilitation Sciences, Hasselt University, Diepenbeek, Belgium.
- Department of Automatics, Biocybernetics and Robotics, Jožef Stefan Institute, Ljubljana, Slovenia.
ORCID-Profile: Myrthe Stalmans, Domen Tominec, Wout Lauriks, Ruben Robberechts, Tadej Debevec, Chiel Poffé
Förderung
- Fonds Wetenschappelijk Onderzoek (FWO)
- Javna Agencija za Raziskovalno Dejavnost RS (ARRS)
Zitieren
APA
Stalmans, M., Tominec, D., Lauriks, W., Robberechts, R., Ramaekers, M., Debevec, T., & Poffé, C. (2026). Ketone monoester intake attenuates exercise performance decline in normobaric hypoxia: A post‐hoc subgroup analysis of 5 young male adults without acute mountain sickness. Physiological Reports. https://doi.org/10.14814/phy2.71136
Vancouver
Stalmans M, Tominec D, Lauriks W, Robberechts R, Ramaekers M, Debevec T, et al. Ketone monoester intake attenuates exercise performance decline in normobaric hypoxia: A post‐hoc subgroup analysis of 5 young male adults without acute mountain sickness. Physiological Reports. 2026. doi:10.14814/phy2.71136
BibTeX
@article{Stalmans2026,
author = {Stalmans, Myrthe and Tominec, Domen and Lauriks, Wout and Robberechts, Ruben and Ramaekers, Monique and Debevec, Tadej and Poffé, Chiel},
title = {Ketone monoester intake attenuates exercise performance decline in normobaric hypoxia: A post‐hoc subgroup analysis of 5 young male adults without acute mountain sickness},
journal = {Physiological Reports},
year = {2026},
doi = {10.14814/phy2.71136}
}
EUVIMED